Cutler Group LP Voyager Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$5.57 - $7.47 $11,140 - $14,940	-2,000 Reduced 26.32%	5,600 $7,000
Q2 2022 Aug 04, 2022	SELL	$4.82 - $10.09 $9,640 - $20,180	-2,000 Reduced 20.83%	7,600 $12,000
Q1 2022 Apr 14, 2022	BUY	$2.75 - $9.44 $26,125 - $89,680	9,500 Added 9500.0%	9,600 $11,000
Q2 2018 Aug 10, 2018	SELL	$16.76 - $23.92 $15,084 - $21,528	-900 Reduced 90.0%	100 $0
Q3 2017 Oct 17, 2017	BUY	$8.37 - $20.59 $8,370 - $20,590	1,000	1,000 $0

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $228M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.